We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Slide Scanner System Provides Pathologists Additional Flexibility in Laboratory Workflow

By LabMedica International staff writers
Posted on 23 Jan 2023
Print article
Image: NanoZoomer S20MD Slide scanner system C16300-21MDEU (Photo courtesy of Hamamatsu Photonics)
Image: NanoZoomer S20MD Slide scanner system C16300-21MDEU (Photo courtesy of Hamamatsu Photonics)

A new automated high-speed digital slide creation, viewing, and management system that enables whole slide imaging for in vitro diagnostic use provides clinical pathologists with additional flexibility in their laboratory workflow.

Hamamatsu Photonics (Shizuoka, Japan) has launched the new NanoZoomer S20MD Slide scanner system (C16300-21MDEU) which completes its existing NanoZoomer line-up of MD models, by offering a medium scale digital pathology routine, ideal for priority scanning during peak production. It is the only whole slide scanner of its kind on the market that can scan approximately one slide every 30 seconds in the ×20 or ×40 mode, thus allowing pathologists to achieve a leaner and more efficient workflow. Additionally, it offers pathologists the possibility of working alongside their existing Sakura slide basket and coverslipper for a lean scanner workflow process, thanks to a new optional adaptor.

The NanoZoomer S20MD also offers excellent image quality as it is designed with the same pixel pathway as Hamamatsu’s high-end model, NanoZoomer S360MD Slide scanner system. Moreover, the integrated image acquisition software (NZAcquireMD) and the image viewing software (NZViewMD) allow users to easily create, view and perform quality checks on whole slide images. In addition to the advanced hardware and software, clinical customers will be supported by trained specialists from Hamamatsu throughout the adoption of new workflows. Hamamatsu has trainings and technical support in place to ensure a smooth transition for clinical pathologists, whether it involves integrating a new scanner model into their workflow or switching from analogue to digital workflow.

Related Links:
Hamamatsu Photonics

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more